• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Maxygen

Maxygen

  1. Five Things Your Credit Manager Shouldn’t Be Doing (But Probably Is)

    Early data from Maxygen's pipeline is encouraging, but key trials are just beginning.

  2. Choosing the Best 529 College Saving Plan

    Maxygen's pipeline is entering the clinic, but its technology remains unproven.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.